Anaemia of moderate severity is commonly present in patients suffering from rheumatoid arthritis. The degree of anaemia bears a close relationship to the activity of the disease. No completely satisfactory explanation of its presence has ever been advanced. In the past it has been ascribed to "toxic" depression of marrow function, iron deficiency, or a combination of these factors. Iron by mouth was usually prescribed, but results were seldom satisfactory. The characteristics of the anaemia have been studied in detail by a number of investigators in recent years, but a review of their reports reveals no general agreement as to underlying causes. Nilsson (1948) stated that the anaemia was of a hypochromic and normocytic type. He considered that the red cells were of abnormal shape in that the mean corpuscular volume (MCV) was within normal limits, but the mean corpuscular diameter was decreased. Inadequate haemoglobinization was apparent from a reduction in the mean corpuscular haemoglobin concentration (MCHC). Jeffrey (1952 Jeffrey ( , 1953a found that the MCV was within the normal range in 74 of 100 cases examined (74 per cent.), whereas the MCHC was less than 30 per cent. (normal range 32-36 per cent.) in 97 of 136 cases (71 per cent.). Ross (1950) confirmed that the anaemia was of hypochromic, normocytic type. Nilsson (1948) and Jeffrey (1952) examined myelograms from twelve and sixteen patients respectively. No consistent abnormality was reported, but in many instances the haemoglobinization of normoblasts was impaired and the production of immature normoblasts increased. Cartwright and Wintrobe (1952) reported that free erythrocyte protoporphyrin was increased in ten or fifteen cases of anaemia in rheumatoid arthritis. That this increase was probably independent of changes in free erythrocyte coproporphyrin content was later shown by Krammer and others (1954) . These findings were interpreted as being indications of retarded erythropoiesis. In the patients studied by Jeffrey (1953b) the free erythrocyte protoporphyrin varied widely from case to case.
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A moderate increase in reticulocytes was noted by Nilsson (1948) in a number of female patients, but he found no evidence of increased haemolysis. Jeffrey (1952 Jeffrey ( , 1953a ) measured serum bilirubin, faecal urobilinogen, the number of reticulocytes, and the fragility of red cells in saline. He concluded that haemolysis was not a significant factor in the causation of this anaemia. Robinson (1943) reported that the anaemia was largely produced by an increase in plasma volume. Jeffrey (1953a) did not consider that changes in plasma volume were of significance. Recently, however, Dixon (1954) has confirmed that a moderate increase in plasma volume occurs in rheumatoid arthritis. Nevertheless, it seems unlikely that mere dilution of the red cell mass could account for hypochromia or the severe degrees of anaemia sometimes encountered. Nilsson (1948) found that in patients in an active phase of rheumatoid disease, marked hypochromic anaemia was relatively common. The relationship between the severity of the anaemia and activity of the arthritis was confirmed by Jeffrey (1952 Jeffrey ( , 1953a , but the degree of hypochromia (as estimated by the MCHC) was commensurate with activity of disease only in female patients.
Abnormalities of the metabolism of iron in rheumatoid arthritis were recognized before the morphological characteristics of the anaemia had been fully described. Bruzzone and Massimello (1940) and Heilmeyer and others (1941) observed that the serum iron level was below normal. This observation has been repeatedly confirmed, and Nilsson (1948) found that hypoferraemia was most marked in patients with severe degrees of anaemia and active arthritis. Jeffrey (1953a) correlated low levels of plasma iron and hypochromia. He reported that the total iron-binding capacity of the plasma was not significantly abnormal-a finding in contrast to the increase in binding capacity found in anaemia directly due to deficiency of iron.
Despite the hypochromic character of the anaemia in rheumatoid arthritis, the response to the administration of iron has been reported as variable. Collins (1935) noted improvement in only five of twelve patients given adequate doses of oral iron. Nilsson (1948) considered that improvement of the anaemia was more directly ANNALS OF THE RHEUMATIC DISEASES related to the onset of natural remission than to the administration of iron by mouth. The introduction of a preparation of saccharated oxide of iron suitable for intravenous administration was followed by reports of its use in rheumatoid arthritis. Sinclair and Duthie (1949) -observed a good response to intravenous iron in sixteen of 23 anaemic patients who had shown no benefit from oral iron. Of the sixteen patients responding adequately, thirteen maintained a satisfactory haemoglobin level for periods ranging from 7 to 23 months. Good haematological response was reported in a further 22 of 28 patients, all of whom had failed to respond to oral iron (Sinclair and Duthie, 1950) . Ross (1950) and Jeffrey (1952 Jeffrey ( , 1953a Jeffrey ( , 1953b confirmed the value of intravenous iron in cases where the anaemia had failed to improve on adequate doses of iron by mouth.
The failure of the majority of cases to respond to oral iron might be explained on the assumption that absorption from the gut is inadequate in rheumatoid arthritis. Nilsson (1948) , using 0-5 g. iron lactate as a test dose, considered that absorption was impaired to some extent, especially in patients with active disease and increased erythrocyte sedimentation rate (E.S.R.). Jeffrey (1953a) reported good absorption from the gut following after a dose of 0-6 g. ferrous sulphate in six patients; three showed exceptionally low resting values of plasma iron (30-36 ,ug. per cent.) and a very large rise in plasma iron following the test dose. In the other three a moderate increase in plasma iron was noted. In eight cases the rise in plasma iron after the same test dose was slight and taken as presumptive evidence of impaired absorption. Sinclair and Duthie (1950) found absorption to be normal in seven anaemic patients. None responded to oral iron, but six responded satisfactorily to intravenous iron. The test dose in these cases was 1 -2 g. ferrous sulphate.
From these studies it seems improbable that the superiority of intravenous iron in the treatment of the anaemia of rheumatoid arthritis can be ascribed to impairment of absorption from the gut. In a small percentage of cases frank iron-deficiency anaemia is present and response to oral or intravenous iron is satisfactory. Sinclair and Duthie (1949) observed that in the presence of a persistently high E.S.R. a satisfactory response to intravenous iron was much less frequent. Jeffrey (1953b) considered that a good response was predictable when one or more of the following features were present: low E.S.R., microcytosis, gross hypochromia, and raised total iron-binding capacity. It should be noted that these conditions occur in simple iron-deficiency anaemia and are not characteristic of the anaemia of rheumatoid arthritis.
Little information is available regarding the immediate fate of saccharated oxide of iron after its intravenous injection in human subjects, although Cappell (1930) described in detail its distribution in animal tissues. He observed that after injection the iron was rapidly removed from circulation and could be demonstrated in leucocytes and in the cells of the reticulo-endothelial system. "These cells appeared to act upon the iron"; in about 72 hours "a soluble iron compound" could be demonstrated in the plasma and this increased in amount during the following weeks. The "soluble iron" was deposited largely in the lymphatic glands and in the parenchyma cells of the liver and kidney. In the mouse, the liver, spleen, and lymphatic glands appeared to be the most important sites of iron storage. The liver parenchyma contained the greatest amount in animals killed in the later stages of the experiment. A similar distribution of iron in human subjects given large doses intravenously has been reported by Kuhns and others (1950) .
From the foregoing review of the literature it would appear that the fundamental cause of anaemia in rheumatoid arthritis remains unknown and that the role of iron in the correction of this anaemia is still unexplained. In a proportion of cases which have failed to respond to adequate doses of iron taken by mouth, improvement occurs after the administration of large doses of intravenous iron. This suggests an increase in the demand for iron which cannot be met by absorption from the gut. In these circumstances it was felt that further studies of the characteristics of the anaemia and of the metabolism of iron in rheumatoid arthritis was well worth while. The object of the present communication is to present the results of the first stage of this investigation.
Material and Methods These studies were conducted on patients suffering from rheumatoid arthritis attending the Rheumatic Unit, Northern General Hospital, Edinburgh. The majority were in-patients. Control material was obtained from members of the staff and from blood donors at the Blood Transfusion Unit, Edinburgh Royal Infirmary.
The preparation of saccharated oxide of iron (S.O.I.) used throughout these experiments was "Iviron", a colloidal solution* containing 20 mg. elemental iron per ml.
Iron.-Samples of blood were collected in iron-free centrifuge tubes, sodium oxalate (1 mg./ml.) being used as an anticoagulant when plasma was required. The method for the measurement of plasma and serum iron was essentially that described by Ramsay (1953) . This method has been found to give values about 15 per cent. higher than other methods reported in the literature. Two modifications of the method were made. In order to decrease the error introduced by slight haemolysis of the blood sample, sodium sulphite (0 5 ml./O IM) was used as the reducing agent in place of hydroxylamine (Ramsay, 1954) . The final solution was centrifuged in place of the filtration recommended in the original method. This eliminated the error introduced by extraction of iron from the filter paper.
It was found that iron in the saccharated oxide is not measured by the above method unless heating of the solution is prolonged to 90 min. Identical results have been obtained by this method and by the "total iron" NATURE OF ANAEMIA IN RHEUMATOID ARTHRITIS. I. method of Ramsay (1950) , when solutions of S.O.I. were used. As a small percentage of the iron in S.O.I. reacts with 2-2'-dipyridyl even after heading for 5 minutes, it has been found impossible to estimate fl'-globulin bound iron in the presence of S.O.I. All values stated represent the total iron content of plasma.
The method as modified for the measurement of S.O.I. was used in determination of iron in urine. Although no iron could be detected in a 24-hour sample of urine, either from normal subjects or from patients suffering from rheumatoid arthritis, recoveries of added ferrous sulphate and of S.O.I. were quantitative.
Iron-Binding Capacity.-This was estimated by the method of Rath and Finch (1949) .
Plasma Protein Fractions.-Plasma proteins were precipitated by appropriate concentrations of Na2SO3 (Howe, 1921) and the protein estimated by the method of Lowry and others (1951) . Bovine fibrinogen was used as the standard. The method was checked periodically by nitrogen determinations using the microKjeldahl technique.
Iron Absorption.-Ferrous sulphate 1 2 g. was given at 10 a.m. Blood was withdrawn for measurement of serum iron at 10 a.m., 12 noon, 2 p.m., and 4 p.m. The subjects were on normal diet.
Bilirubin.-Bilirubin was measured by the method of Haslewood and King (1937) , a recrystallized sample of bilirubin being used as the standard.
Bromsulphophthalein Retention Test.-The method of Mateer and others (1943) was used. The amount of dye retained 30 and 45 minutes after administration was measured.
Results
Chemical and Physical Properties of Saccharated Oxide of Iron.-Since a proprietary preparation of saccharated oxide of iron was to be used in these studies, it was considered important to examine its chemical and physical properties in detail.
"Iviron" is a stable colloidal solution of a complex of iron and a non-reducing carbohydrate residue to which the iron is very firmly bound. Boiling with N-HC1 or N-NaOH releases the iron and the solution then reduces Benedict's reagent. Iron may also be liberated, but more slowly, by incubation of S.0. Kerr and Ramsay (1954) . Over the pH range 7. 1-8 6 S.O.I. was found to be preferentially adsorbed on to the filter paper and only the P'-globulin bound iron could be detected in the protein fractions by the method given by Kerr and Ramsay (1954) . The quantity of this iron was probably increased by small amounts of iron liberated by slow hydrolysis of S.O.I. during the 18 hours required for separation of the proteins. S.O.I., even in the presence of protein, is easily adsorbed from solution by cellulose, alumina, and certain ion exchange resins. As a method of determining the association, if any, of S.O.I. and protein, the plasma protein fractions were precipitated with (NH4)2SO4, Na2SO3, or cold ethanol (Cohn and others, 1946) . From these experiments, using plasma to which S.0.1. had been added to give an iron concentration of 4-6 mg./100 ml., it appeared that S.O.I. was firmly bound by the fibrinogen fraction and only loosely bound by the globulin and albumin fractions. The fibrinogen-S.O.I. complex was not dissociated by washing with saline or by reprecipitation, and chemical analysis showed that 1 ,ug. iron combined with approximately 50 ptg.
fibrinogen. In both plasma and serum the albumin and globulin complexes were found to be much less stable, and analysis suggested a ratio of 1 : 1,000 rather similar to that of iron in the P'-globulin Table 11 (opposite). Serum iron levels before administration of the test dose ranged from 45-125 ig./100 ml. in the rheumatoid group (mean 87 ug. 100 ml.). In the normal subjects, none of whom was anaemic, the range was from 90-207 Lcg./100 ml. (mean 158 ug./ 100 ml.). After the administration of 1-2 g. ferrous sulphate the rise in serum iron ranged from 42-202 ig./100 ml. (mean 102 ug./l00 ml.) in the rheumatoid group, and from 72-185 flg./ 100 ml.
(mean 110 ug.1100 ml.) in normal subjects. In one case of rheumatoid arthritis and in one normal subject no rise of serum iron occurred.
Distribution of Iron between Plasma and Serum after the Intravenous Injection of S.O.I. After the injection of 10 ml. of the solution of S.O.I., the distribution of iron between serum and plasma was studied in three normal individuals and eight rheumatoid patients. Examples of the results of these experiments are shown in Fig. 2 (opposite) .
The concentration of iron was greater in plasma than in serum in all instances where the iron level exceeded 1,000 ug./100 ml. It was possible to shove by precipitation that this additional iron was associated with the fibrinogen. The level of fibrinogen in the plasma did not appear to bear any relationship to the quantity of iron adsorbed, both normal subjects and patients with marked elevation of fibrinogen giving similar results. It Rath and Finch (1949) , the standard deviation being calculated from the data in Table If Table IV shows that the maximum excretion of iron occurred during the first 2 hours after injection, corresponding to the highest concentrations of iron in the plasma. Urine was collected for 6 hours after injection in seven normal subjects and sixteen patients. The mean value for iron excreted by the normal group was 6,114 [ug. ± 1,280 ,tg., and that for the patients was only 3,219 ,ug. ± 1,301 [ig.
It seemed possible that, as the saccharated oxide of iron preparation had been found to be non- ritis. Only in the normal group was any change formed before injection of S.O.I., 3 days after noted (Fig. 5) . After a delay of 1-3 days there was a injection (when the maximum change in bilirubin rise in the bilirubin concentration, which did not, concentration was found), and 7 days after injection however, exceed normal limits (1 mg./100 ml.). The *when the bilirubin concentration had returned to concentration fell to the pre-injection level in 9 days. pre-injection value.
As these results suggested transient impairment of Table V records changes in the B.S.P. retention liver function, the B.S.P. retention test was per-test which occurred in four normal subjects in whom ANNALS OF THE RHEUMATIC DISEASES there was a rise in plasma bilirubin following injection of S.O.I. In four cases of rheumatoid arthritis no such rise in plasma bilirubin or change in B.S.P. retention occurred.
Discussion
Measurements of the plasma iron concentration in patients suffering from rheumatoid arthritis confirmed the presence of subnormal values, more marked in females than in males, although these levels were considerably above those found in true iron deficiency (Smith, 1952) . Investigation of iron absorption from the gut revealed little evidence of impairment when the results were compared with those in normal controls given the same dose by mouth. This is in contrast to the diminished absorption reported by Cartwright and others (1946) in patients suffering from anaemia complicating infection, although these workers believe that rapid removal of iron from the plasma may partly explain the minimal rise which followed the test dose.
Before going on to study the fate of S.O.I. after injection by the intravenous route it was considered essential to define in as much detail as possible the physical and chemical properties of S.O.I. It was found that, to measure the iron content of solutions of this preparation by the method used, heating had to be prolonged to 90 minutes. Many recent reports of levels of iron in the plasma after intravenous injection of S.O.I. are of no significance because only variable fractions of the iron were measured (Cameron and others, 1951) .
It has also been shown that the solution used is non-homogeneous and that the iron-carbohydrate complex is of varying molecular size. By in vitro experiments it was possible to show that S.O.I. in concentrations of 4 to 6 mg. Fe/100 ml. was firmly bound by fibrinogen, and combined only loosely with albumin and globulin. When the concentration of S.O.I. in plasma was reduced to 1 mg. Fe/lOO ml. no linkage with protein took place. This observation was confirmed when the distribution between plasma and serum iron was studied in vivo after the injection of 10 ml. S.O.I. From this it is obvious that, when iron levels are measured immediately after the injection of S.O.I., plasma, not serum, must be used. The possible significance of the combination of S.O.I. with fibrinogen is not apparent at the present time.
By measurement of the iron-binding capacity at intervals after injection it was shown that it slowly fell to zero during the following 6 hours, in both normal subjects and rheumatoid patients, indicating a slow hydrolysis of the S.O.I. The combination of rapid removal and slow hydrolysis provides an explanation for the absence of toxic effects, which are believed to be due to the presence of free ionic iron (Cartwright and Wintrobe, 1949) .
Daily measurement of plasma iron after a single injection of 10 ml. S.O.I. showed that in the majority of patients with rheumatoid arthritis the iron was cleared within 24 hours, whereas in normals clearance was rarely complete before 72 hours. This could not be explained by increased excretion in the urine. Rheumatoid patients were found to excrete a smaller proportion of the dose given than normal controls. Similar observations regarding the rapid clearance of non-colloidal preparations of iron from the plasma in patients with rheumatoid arthritis have been recorded by Nilsson (1948) Mills and Dragstedt (1936) found that there was abnormal retention of bromsulphophthalein in animals after injection of indian ink and saccharated oxide of iron. It is clear that a much more detailed study of liver function after administration of iron by the intravenous route in normal subjects and patients suffering from rheumatoid arthritis will be necessary before the significance of the differences found can be assessed, but these preliminary observations provide some additional evidence of abnormal metabolism of iron in this disease. It has been suggested by Cartwright and Wintrobe (1952) that, in the anaemia of infection, an increased demand for iron by the cells of the reticulo-endothelial system may account for the hypoferraemia and the rapid clearance of iron from the blood. They state, however, that nothing is known of the function iron may fulfil in these circumstances. The apparent derangement of iron metabolism in rheumatoid arthritis conforms to a similar pattern, although there is no evidence that infection plays a significant part in this disease.
The common factor would appear to be extensive tissue damage. The relationship between anaemia and abnormal metabolism of iron is by no means clear. The characteristics of the anaemia in rheumatoid arthritis differ significantly from those of true iron deficiency anaemia. The red cells are of normal size, the iron-binding capacity of the plasma is normal, and, although plasma iron levels are subnormal, it would appear unlikely that the reduction in both haemoglobin concentration and red cell count are explained solely by deviation of iron from the marrow. The authors have obtained unequivocal evidence (to be reported in a later communication) that the survival of normal red cells transfused to patients with active rheumatoid arthritis is substantially reduced. This would suggest that reduction in the survival time of the patient's own red cells may be of importance. In these circumstances the improvement in anaemia which follows the administration of large doses of S.O.I. intravenously may depend to some extent at least on actions other than an increase in the amount of iron available to the marrow. Cappell's observation that, in animals given saccharated oxide of iron, the metal is slowly transferred from the cells of the reticulo-endothelial system to those of the liver parenchyma may be of some significance in this connection. The haematological response to intravenous iron in patients with rheumatoid arthritis may not attain its maximum for 2-3 months; there is no correlation between plasma iron levels and improvement in the anaemia, and the amount of S.O.I. required to produce a response is often far in excess of that calculated to restore the haemoglobin concentration to normal. These preliminary studies have not revealed the cause of anaemia in rheumatoid arthritis, but the presence of marked abnormality in the metabolism of iron in this disease has been confirmed. The mode of action of iron complexes given intravenously is not clear, but it is felt that a more complete knowledge of their initial distribution and ultimate localization is of great interest. Summary (I) Previous work on the nature of anaemia in rheumatoid arthritis and the metabolism of iron in this disease has been reviewed.
(2) The existence of significant degrees of hypoferraemia in the presence of normal iron-binding capacity has been confirmed.
(3) No evidence of impaired absorption of iron from the gut has been obtained.
(4) The physical and chemical properties of a commercial preparation of saccharated oxide of iron have been examined.
(5) The rate of removal of iron from the plasma after intravenous injection of the saccharated oxide is more rapid in patients with rheumatoid arthritis than in healthy individuals. The more rapid clearance from the blood is not accounted for by excretion in the urine.
(6) Evidence of transient impairment of liver function in normal individuals after a single injection of saccharated oxide of iron has been obtained. No signs of interference with liver function have been found in patients with rheumatoid arthritis.
(7) The relationship between the derangement of iron metabolism and the occurrence of anaemia in rheumatoid arthritis is not clear, nor has any adequate explanation been found for the improvement in anaemia which follows the administration of saccharated oxide of iron in some cases.
